Salzburg Breast Cancer Talk

Prof. Richard Greil MD
Head of the IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Prof. Gabriel Rinnerthaler MD
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer, Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Prof. Simon P. Gampenrieder MD
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Prof. Peter Schmid FRCP MD PhD
Centre Lead, Centre for Experimental Cancer Medicine, Director, Breast Cancer, St Bartholomew, Hospital London, London, United Kingdom
Prof. Dipl.-Ing. Dr. Zlatko Trajanoski
Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Austria
Marleen Kok MD PhD
Medical Oncologist and Groupleader Tumor biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands
Prof. Eric Vivier DVM PhD
Professor, Aix Marseille Univ, CNRS, INSERM, Centre d’Immunologie de Marseille-Luminy, Scientific Director- Innate Pharma Research Labs and President- Paris-Saclay Cancer Cluster, Marseille, France
Prof. Dr. Niels Schaft PhD
Research Group Leader of the RNA-based Immunotherapy group, Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
Prof. Laurence Zitvogel MD PhD
Gustave Roussy Comprehensive Cancer Institute, Villejuif, France
Université Paris Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France, INSERM U1015, Villejuif, France
Prof. Dr. Fritz Aberger
Molecular Cancer and Stem Cell Research, Lab Department of Molecular Biology, University of Salzburg, Cancer Cluster Salzburg (CCS), Salzburg, Austria
Dr. Iosifina Foskolou
Group Leader at Sanquin Research, Amsterdam, The Netherlands
Emanuela Romano MD PhD
Medical Director, Center for Cancer Immunotherapy, Department of Oncology, INSERM U932, Institut Curie, Paris, France
Prof. Dr. Udo Gaipl
Head of Translational Radiobiology, Universitätsklinikum Erlangen, Department of Radiation Oncology, Erlangen, Germany
Dr. Roberto Salgado
Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Australia
Prof. Dr. Barbara Seliger
Director of the Institute for Medical Immunology, Martin Luther University, Medical Faculty, Halle, Germany
Karen Willard-Gallo MD PhD
Head, Molecular Immunology Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Giampaolo Bianchini MD
Associate Professor – Università Vita-Salute San Raffaele, Head Breast Cancer Group – Department of Medical Oncology, Head clinical translational and immunotherapy research, Ospedale San Raffaele, Milano, Italy

5th SALZBURG BREAST CANCER TALK – Mastering translational Immuno-Oncology is applied for 11 DFP points at the Diploma Continuing Education Programme of the Austrian Medical Association (ÖÄK).

Hotel Gersbergalm

Gersberg 37
5020 Salzburg

The hotel can be reached by car (sufficient parking available), by bus (line 151) or by cab (still city area).

Prof. Dr. Richard Greil

Dr. Simon P. Gampenrieder
Dr. Gabriel Rinnerthaler

AGMT gemeinnützige GmbH

Salzburg Cancer Research Institute (SCRI) with Laboratory of Immunological and Molecular Cancer Research (SCRI-LIMCR)

Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT)

in Kooperation mit
Cancer Cluster Salzburg | www.cancercluster-salzburg.at

Photos: Franz Neumayr